Back to Evidence

Paper-scoped peptide mentionSequence reported

LRIPVA

PMC5446464::PEP000141

Source publication

STRUCTURAL CHARACTERISTICS AND ANTIHYPERTENSIVE EFFECTS OF ANGIOTENSIN-I-CONVERTING ENZYME INHIBITORY PEPTIDES IN THE RENIN-ANGIOTENSIN AND KALLIKREIN KININ SYSTEMS.

African Journal of Traditional, Complementary, and Alternative Medicines · 2017

DOI 10.21010/ajtcam.v14i2.39 PMC5446464 PMID 28573254

Sequence status: reported
Standardization: Sequence ready
Source location: unknown
Activity records: 2

Sequence evidence

Reported molecular identity

LRIPVA

LRIPVA

Resolved peptide links

PEPDIA-PLP-003857 CTPDB_P025875

Experimental observations

Records linked to this mention

Metabolic/CardiovascularACE InhibitorPositive observation

Table 1: Spinach rubisco, LRIPVA, IC50 0.38 µM.

Mention PMC5446464::PEP000141PMC5446464table

Measure: other
Value: 0.38 µM
Target: Angiotensin-I-converting enzyme
Assay: Not reported by source

Source publication

Metabolic/CardiovascularACE InhibitorPositive observation

Table 3: Spinach rubisco, LRIPVA, 100 mg/kg, 0 mmHg reduction.

Mention PMC5446464::PEP000141PMC5446464table

Measure: survival_rate
Value: 0 mmHg
Target: Rattus norvegicus
Assay: Not reported by source

Source publication

Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.